The FDA has issued a draft guidance to simplify the procedure of developing drugs for rare pediatric disorders.
A therapy for hemophilia A originally only approved for adult patients has now been approved for use in children under the age of 12 years by the FDA.
Doctors risk treatment failure if they prescribe a shorter course of antibiotics for acute otitis media in children under 2.
Guidelines for the use of ciprofloxacin and levofloxacin in children were recently published in an updated clinical report from the American Academy of Pediatrics Committee on Infectious Diseases.
A new model can identify the optimal busulfan cumulative AUC range for children and young adults undergoing hematopoietic cell transplantation.